ACADIA PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Acadia Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Acadia Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $52.4M, a 0.02% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $52.4M +$8K +0.02% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $54.3M +$129K +0.24% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $51.9M -$3.72M -6.69% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $50.8M -$5.87M -10.4% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $52.4M -$5.04M -8.77% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $54.2M -$4.04M -6.94% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $55.6M -$2.7M -4.63% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $56.6M -$3.41M -5.68% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $57.4M -$3.95M -6.44% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $58.2M -$4.93M -7.8% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $58.3M +$11M +23.2% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $60M +$11.8M +24.5% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $61.4M +$53.5M +679% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $63.1M +$54.5M +633% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $47.3M +$37.8M +396% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $48.2M +$38.3M +384% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $7.88M -$2.94M -27.2% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $8.61M -$2.31M -21.1% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $9.52M +$9.52M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $9.96M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $10.8M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $10.9M Mar 31, 2019 10-Q 2019-05-02
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.